Copyright © 2005 Elsevier SAS All rights reserved.
Review
Pleuropulmonary involvement in ankylosing spondylitis
Received 8 December 2003;
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Abstract
Pleuropulmonary involvement was long described as an uncommon and late event in the course of ankylosing spondylitis (AS). This belief was based on studies that relied on symptoms and chest radiographs to evaluate the lungs. However, pleuropulmonary involvement in AS patients is usually asymptomatic, and the early lesions are undetectable on chest radiographs. Apical fibrosis, interstitial infiltrates, and pleural thickening were considered to be the main patterns. However, the introduction of high-resolution computed tomography (HRCT) has led to the description of many pulmonary abnormalities that are clinically silent and undetectable on plain radiographs. These abnormalities mainly affect the interstitium and have no influence on respiratory function, which is dependent on the severity of chest wall inflammation or ankylosis in recent-onset and established AS, respectively. Cytological and histological studies suggest that, in common with uveitis and aortic regurgitation, the structural lung changes shown by HRCT may be specific of AS.
Keywords: Ankylosing spondylitis; Computed tomography of the chest; Lungs; Apical fibrosis; Lung function testing
Article Outline
- 1. Introduction
- 2. Historical overview
- 3. Chest radiographs
- 4. High-resolution computed tomography
- 5. Lung function testing
- 6. Bronchoalveolar lavage
- 7. Histological studies
- 8. Etiological and pathogenic hypotheses
- 8.1. Mechanical theory
- 8.2. Disease-specific theory
- 9. Evaluation of pulmonary involvement in clinical practice
- 10. Treatment and follow-up
- References







E-mail Article
Add to my Quick Links

Cited By in Scopus (3)






